Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Protagonist Therapeutics ...

    NASDAQ: PTGX · Real-Time Price · USD
    56.13
    0.06 (0.11%)
    At close: Aug 18, 2025, 3:59 PM
    56.11
    -0.04%
    Pre-market: Aug 19, 2025, 07:06 AM EDT

    Protagonist Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 275.19M -78.95M -127.39M -125.55M
    Depreciation & Amortization
    		 2.9M 3.31M 3.37M 2.77M
    Stock-Based Compensation
    		 37.55M 29.29M 24.2M 16.39M
    Other Working Capital
    		 31.55M -16.58M -9.81M -1.92M
    Other Non-Cash Items
    		 -8.88M -4.38M -549K 1.83M
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 -122.61M -19.51M -7.77M -3.31M
    Operating Cash Flow
    		 184.15M -70.24M -108.14M -107.86M
    Capital Expenditures
    		 -1.35M -609K -795K -1.1M
    Cash Acquisitions
    		 n/a n/a -91.47M 14.76M
    Purchase of Investments
    		 -621.7M -191.04M -214.87M -286.59M
    Sales Maturities Of Investments
    		 323.57M 152.4M 307.14M 271.83M
    Other Investing Acitivies
    		 n/a n/a 91.47M -14.76M
    Investing Cash Flow
    		 -299.48M -39.26M 91.47M -15.86M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 25.85M 38.38M 4.29M 6.09M
    Financial Cash Flow
    		 25.85M 170.48M 18.84M 129.92M
    Net Cash Flow
    		 -89.48M 60.98M 2.08M 6.07M
    Free Cash Flow
    		 182.8M -70.84M -108.93M -108.97M

    Add to Watchlist